info@synchemia.com | sales@synchemia.com 
9766925136 
Darunavir
Darunavir | CAS NO: 206361-99-1 , Darunavir (Prezista) is an antiretroviral protease inhibitor used to treat HIV-1 infection in adults and children (3 years and older) by blocking viral replication. It is always taken with other HIV medications, usually boosted by ritonavir or cobicistat, to manage HIV infection and lower the risk of infection after potential exposure.
We are the Synchemia Research Chemical specializes in manufacturing and supplying of Darunavir impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities. Darunavir (Prezista) is an antiretroviral protease inhibitor used to treat HIV-1 infection in adults and children (3 years and older) by blocking viral replication. It is always taken with other HIV medications, usually boosted by ritonavir or cobicistat, to manage HIV infection and lower the risk of infection after potential exposure. Buy Reliable and High-Purity Darunavir Impurities, Delivered by Synchemia Research Chemicals.
Download catalogue
Pharmaceutical Reference Standards
| CAT No | SRC-D3867 |
| CAS No | 799241-86-4 |
| Mol.F. | C11H13NO7 |
| Mol.Wt. | 271.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3868 |
| CAS No | 253265-97-3 |
| Mol.F. | C11H13NO7 |
| Mol.Wt. | 271.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3869 |
| CAS No | NA |
| Mol.F. | C48H64N6O11S2 |
| Mol.Wt. | 965.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3870 |
| CAS No | 1526916-56-2 |
| Mol.F. | C21H29N3O5S |
| Mol.Wt. | 435.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3871 |
| CAS No | 1526916-57-3 |
| Mol.F. | C22H31N3O5S |
| Mol.Wt. | 449.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3872 |
| CAS No | NA |
| Mol.F. | C49H62N6O9S2 |
| Mol.Wt. | 943.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3873 |
| CAS No | NA |
| Mol.F. | C34H45N3O11S |
| Mol.Wt. | 703.8g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3874 |
| CAS No | NA |
| Mol.F. | C34H45N3O11S |
| Mol.Wt. | 703.8g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3875 |
| CAS No | 2307745-62-4 |
| Mol.F. | C34H53N3O6 |
| Mol.Wt. | 599.8g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3876 |
| CAS No | NA |
| Mol.F. | C35H43N3O9S |
| Mol.Wt. | 681.8g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3877 |
| CAS No | 1402142-62-4 |
| Mol.F. | C20H29N3O3S |
| Mol.Wt. | 391.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3878 |
| CAS No | 799241-73-9 |
| Mol.F. | C27H37N3O7S |
| Mol.Wt. | 547.7g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3879 |
| CAS No | 799241-75-1 |
| Mol.F. | C27H37N3O7S |
| Mol.Wt. | 547.7g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3880 |
| CAS No | 1349180-32-0 |
| Mol.F. | C18H30N2O3 |
| Mol.Wt. | 322.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3881 |
| CAS No | 1159613-25-8 |
| Mol.F. | C33H45N3O13S |
| Mol.Wt. | 723.8g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3882 |
| CAS No | NA |
| Mol.F. | C21H27N3O4S |
| Mol.Wt. | 417.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Let’s advance your research together.
Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.
